Background
Transesophageal echocardiography (TEE) plays an important role in evaluating cardioembolic sources of emboli. The identification of a patent foramen ovale (PFO) is reportedly improved with TEE compared with transthoracic echocardiography (TTE), but the Valsalva maneuver during TEE may be difficult or suboptimal. The aim of this study was to assess the efficacy of the Valsalva maneuver for PFO diagnosis using TEE compared with TTE by evaluating patients with ischemic stroke referred for echocardiography.
Methods
Only patients able to perform the Valsalva maneuver during TTE were included; efficacy was defined by a 20 cm/sec decrease in transmitral E velocity. A PFO was judged present when microbubbles of agitated intravenous saline were seen in the left chambers within three cycles after right atrial opacification.
Results
Of 108 patients (mean age, 55 ± 15 years; 61 men), 48 (44%) were judged to have PFOs by TEE and/or TTE. In 36 patients (33% of the total, 75% of those with PFOs), microbubbles were observed both by TEE and TTE, in seven patients only during TTE, and in five patients only during TEE. In patients able to satisfactorily perform the Valsalva maneuver during TEE, 22 PFOs were found, and two shunts (9%) were missed, whereas in patients unable to perform this maneuver, 26 PFOs were observed, with five shunts missed (19%) ( P < .05). When a PFO was missed by TTE, either the echocardiographic window was suboptimal or the shunt was small.
Conclusions
An adequate Valsalva maneuver is crucial for diagnosis of PFO; most patients with stroke may be screened using TTE with contrast and the Valsalva maneuver, with TEE indicated in case of suboptimal transthoracic images.
Stroke is a significant cause of morbidity in younger patients; a causal relationship between patent foramen ovale (PFO) and stroke is controversial, though some investigations have shown a higher prevalence of PFO in patients with cryptogenic stroke than in those with stroke of known etiology. Transesophageal echocardiography (TEE) plays a major role in evaluating cardioembolic sources of emboli in patients with ischemic cerebrovascular accidents (CVAs) because of its improved imaging of cardiac structures and easier identification of a PFO with the use of intravenous agitated saline contrast compared with transthoracic echocardiography (TTE). Some studies comparing TTE with harmonic imaging to TEE, however, have shown similar results for PFO detection with both methodologies. It remains a matter of debate if TTE could replace TEE as the method of choice to identify the presence of a PFO. However, for a maximally effective contrast evaluation, both examinations require an adequately performed Valsalva maneuver. Accordingly, we assessed the efficacy of Valsalva maneuver in PFO diagnosis by TEE in patients with ischemic CVAs.
Methods
Patients
The study population consisted of all patients with clinical diagnoses of ischemic CVA at our hospital between December 2009 and January 2011. Specifically, we included patients aged >18 years, of both sexes, referred from the neurology clinic with clinical diagnoses of recent (<7 days) ischemic CVA confirmed by brain computed tomography or magnetic resonance. Exclusion criteria were obvious potential cardioembolic sources (atrial fibrillation, mitral stenosis, and intracardiac thrombus). Because the purpose of this study was to test efficacy of the Valsalva maneuver during TEE, we used TTE to preselect patients who were able to perform the Valsalva maneuver; inability to perform the Valsalva maneuver during TTE because of cognitive or coordination impairment was a criterion for exclusion.
Comprehensive TTE (Aplio, with harmonic imaging capability; Toshiba, Tokyo, Japan) was undertaken to exclude potential cardiac causes for stroke. Afterward, patients were instructed to perform the Valsalva maneuver, and its efficacy was tested. The echocardiographer placed a hand on the patient’s abdomen to check for abdominal muscular contraction when acquiring images and while the efficacy of the Valsalva maneuver was assessed by Doppler. We used a 20 cm/sec decrease in transmitral early (E) flow velocity as an objective criteria for adequate strain phase of the Valsalva maneuver. This criterion has been described as an adequate preload reduction during the assessment of diastolic function. However, because this maneuver creates sufficient intrathoracic pressure to decrease preload, it is probably sufficient to also increase the right atrial–to–left atrial pressure gradient during the release phase of the Valsalva maneuver. In addition to this Doppler assessment of preload change and the palpation of muscular abdominal contraction, we also looked for leftward deviation of the atrial septum during imaging. We found that abdominal contraction could be used as a means of judging the effectiveness of the Valsalva maneuver, because it could be assessed during both TTE and TEE, while atrial septal bulging was better observed during TEE. Contrast injections were administered up to three times during the Valsalva maneuver, with images obtained from the apical four-chamber view. A complete transesophageal echocardiographic examination followed TTE on the same day, using the same echocardiographic equipment and a 5-MHz multiplane probe. After oropharyngeal anesthesia, midazolam (0.05 mg/kg) was used for conscious sedation in an intravenous bolus of 1 to 2 mg before and during TEE. Blood pressure, pulse oximetry, and the electrocardiogram were monitored. A search for other cardiac sources of emboli (assessment of the aorta and left atrial appendage) was systematically undertaken. Images of the interatrial septum were obtained from the best imaging plane for septal membrane visualization, typically 50° to 60°. The Valsalva maneuver was then attempted during TEE, simultaneous with abdominal strain assessment. In case the Valsalva maneuver was ineffective, forced abdominal compression and cough were used to complement the examination. At least three saline contrast injections were undertaken during TEE; additional contrast injections were administered with images obtained from other TEE planes if the site of microbubbles passage in the septum was not clear. Contrast injections consisted of 1 mL blood, 1 mL air, and 8 mL saline agitated with a three-way stopcock with two connected syringes, one filled with saline, and administered intravenously from an antecubital vein. Contrast was injected during the strain phase of the Valsalva maneuver, and normal respiration resumed as the first bubbles appeared in the right atrium. A PFO was judged to be present when microbubbles were seen in the left chambers within three cycles after full opacification of the right chambers. Quantification of left atrial opacification was regarded as grade I (mild; one to five microbubbles), grade II (moderate; six to 20 microbubbles), or grade III (important; >20 microbubbles).
Statistical Analysis
Data are expressed as mean ± SD or as percentages. Student’s t test was used to compare groups, and χ 2 tests were used for categorical variables. Agreement was tested using κ statistics. Selected digitally captured images were reviewed by two different observers for microbubble presence and quantification. In case of discordance, a third observer’s opinion was requested. P values < .05 were regarded as significant. The study was approved by the ethics committee of the institution; patients gave written consent for the examination.
Results
Of 117 patients who underwent TEE for the purpose of evaluation of a cardioembolic source of CVA, 108 were included in the protocol. Five patients were not able to perform the Valsalva maneuver because of neurologic disability and were excluded from the study. One patient with left ventricular apical akinesia with a thrombus and three others with atrial fibrillation were also excluded. None of the patients were excluded because of poor transthoracic imaging quality. More contrast injections were used for TEE than for TTE (3.6 ± 0.6 vs 3.1 ± 0.2, P < .001), because of the need for multiple provocation maneuvers.
Of 108 patients (mean age, 55 ± 15 years; 61 men), 48 (44%) were judged to have PFOs after contrast administration by TEE and/or TTE: in 36 patients, microbubbles were observed by both methodologies ( Figure 1 ); in seven patients, microbubbles were seen only during TTE ( Figure 2 ); and in five patients, microbubbles were detected only by TEE ( Figure 3 ). Figure 4 depicts a diagram of the results. During TEE, 42 patients (39%) were able to satisfactorily reproduce the Valsalva maneuver, and PFOs were detected in 22 of these patients. TEE missed the PFOs in two of those with positive results on TTE, yielding a false-negative rate of 9%. In the 66 patients (61%) unable to perform the Valsalva maneuver during TEE, PFOs were detected in 26 by TEE. TEE missed five PFOs in patients with positive results on TTE, yielding a false-negative rate of 19% ( P < .05; Figure 5 ). The mean midazolam dose during TEE was not significantly different for patients capable and incapable of performing the Valsalva maneuver (3.6 ± 2.3 vs 4.4 ± 3.1 mg, respectively, P = NS). There were no complications associated with the examinations.
Of five patients with PFOs missed by TTE, three had suboptimal echocardiographic windows and images, and in the remaining two, the shunts demonstrated by TEE were very small (grade I). Overall, there was good agreement between TTE and TEE regarding the presence or absence of a PFO (agreement, 89%; κ = 0.76). However, the semiquantitative evaluation of left chamber opacification showed only moderate agreement between TEE and TTE (agreement, 66%; κ = 0.42). Most disagreement was found for microbubble quantification between grades II and III, with TTE showing larger shunts than TEE in 14% of the patients. Disagreement regarding quantification of shunt was never more than one grade for any of the methodologies ( Table 1 ).
TTE (grade) | TEE (grade) | Total | ||
---|---|---|---|---|
I | II | III | ||
I | 3 (8.6%) | 2 (5.7%) | 0 (0%) | 5 (14.3%) |
II | 3 (8.6%) | 4 (11.4%) | 2 (5.7%) | 9 (25.7%) |
III | 0 (0%) | 5 (14.3%) | 16 (45.7%) | 21 (60.0%) |
Total | 6 (17.1%) | 11 (31.4%) | 18 (51.4%) | 35 (100.0%) |
Among other echocardiographic findings, TEE disclosed aortic atheroma in 21% of patients, mainly restricted to the aortic arch (13%) and descending aorta (10%). Interatrial septal aneurysm was diagnosed in 17% of the patients. In three patients, left chamber opacification was thought to be due to an extracardiac shunt (microbubbles observed after three cardiac cycles).
Results
Of 117 patients who underwent TEE for the purpose of evaluation of a cardioembolic source of CVA, 108 were included in the protocol. Five patients were not able to perform the Valsalva maneuver because of neurologic disability and were excluded from the study. One patient with left ventricular apical akinesia with a thrombus and three others with atrial fibrillation were also excluded. None of the patients were excluded because of poor transthoracic imaging quality. More contrast injections were used for TEE than for TTE (3.6 ± 0.6 vs 3.1 ± 0.2, P < .001), because of the need for multiple provocation maneuvers.
Of 108 patients (mean age, 55 ± 15 years; 61 men), 48 (44%) were judged to have PFOs after contrast administration by TEE and/or TTE: in 36 patients, microbubbles were observed by both methodologies ( Figure 1 ); in seven patients, microbubbles were seen only during TTE ( Figure 2 ); and in five patients, microbubbles were detected only by TEE ( Figure 3 ). Figure 4 depicts a diagram of the results. During TEE, 42 patients (39%) were able to satisfactorily reproduce the Valsalva maneuver, and PFOs were detected in 22 of these patients. TEE missed the PFOs in two of those with positive results on TTE, yielding a false-negative rate of 9%. In the 66 patients (61%) unable to perform the Valsalva maneuver during TEE, PFOs were detected in 26 by TEE. TEE missed five PFOs in patients with positive results on TTE, yielding a false-negative rate of 19% ( P < .05; Figure 5 ). The mean midazolam dose during TEE was not significantly different for patients capable and incapable of performing the Valsalva maneuver (3.6 ± 2.3 vs 4.4 ± 3.1 mg, respectively, P = NS). There were no complications associated with the examinations.